Advertisement

Imaging in Gastrointestinal Cancers

  • Ali Devrim Karaosmanoglu
  • Mehmet Ruhi Onur
  • Ronald S. Arellano
Chapter

Abstract

This chapter provides a general overview of the common diagnostic imaging findings and optimal use of imaging technologies in the diagnosis, follow-up, and screening of gastrointestinal tract cancers. With the development of state-of-the-art technologies and increased experience with these modalities, imaging is generally the first diagnostic tool employed by physicians in modern medical practice. Imaging modalities such as ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography-computed tomography (PET-CT) can be used in detecting as well as staging of the gastrointestinal cancers.

Keywords

Gastrointestinal cancer  Ultrasonography  Computed tomography  Multidetector computed tomography  Magnetic resonance imaging  Positron emission tomography  Diagnosis  Screening  Staging 

References

  1. 1.
    Pourhoseingholi MA, Vahedi M, Baghestani AR. Burden of gastrointestinal cancer in asia; an overview. Gastroenterol Hepatol Bed Bench. 2015;8(1):19–27.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400–12.PubMedCrossRefGoogle Scholar
  3. 3.
    Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, et al. Esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87(4):1048–54; discussion 1054-1045.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008;103(11):2694–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Fitzgerald RH Jr, Bartles DM, Parker EF. Tracheoesophageal fistulas secondary to carcinoma of the esophagus. J Thorac Cardiovasc Surg. 1981;82(2):194–7.PubMedGoogle Scholar
  8. 8.
    Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, et al. Autopsy findings in 111 cases of esophageal cancer. Cancer. 1981;48(2):329–35.PubMedCrossRefGoogle Scholar
  9. 9.
    Sannohe Y, Hiratsuka R, Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981;141(2):216–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Iyer RB, Silverman PM, Tamm EP, Dunnington JS, DuBrow RA. Diagnosis, staging, and follow-up of esophageal cancer. AJR Am J Roentgenol. 2003;181(3):785–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH. Esophageal carcinoma: current concepts in the role of imaging in staging and management. Can Assoc Radiol J. 2015;66(2):130–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Halvorsen RA Jr, Thompson WM. Ct of esophageal neoplasms. Radiol Clin N Am. 1989;27(4):667–85.PubMedGoogle Scholar
  13. 13.
    Pongpornsup S, Posri S, Totanarungroj K. Diagnostic accuracy of multidetector computed tomography (mdct) in evaluation for mediastinal invasion of esophageal cancer. J Med Assoc Thail. 2012;95(5):704–11.Google Scholar
  14. 14.
    Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29(2):403–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Munden RF, Macapinlac HA, Erasmus JJ. Esophageal cancer: the role of integrated ct-pet in initial staging and response assessment after preoperative therapy. J Thorac Imaging. 2006;21(2):137–45.PubMedCrossRefGoogle Scholar
  16. 16.
    van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, et al. Systematic review of the staging performance of 18f-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22(18):3805–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Karaosmanoglu AD, Blake MA. Applications of pet-ct in patients with esophageal cancer. Diagn Interv Radiol. 2012;18(2):171–82.PubMedGoogle Scholar
  18. 18.
    Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18f-fdg-pet) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg. 2006;243(4):472–8.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, et al. Pet to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the municon phase ii trial. Lancet Oncol. 2007;8(9):797–805.PubMedCrossRefGoogle Scholar
  20. 20.
    Hallinan JT, Venkatesh SK. Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response. Cancer Imaging. 2013;13:212–27.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63(1):64–71.PubMedCrossRefGoogle Scholar
  22. 22.
    Parkin DM, Bray FI. Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4–66.PubMedCrossRefGoogle Scholar
  23. 23.
    Davies J, Chalmers AG, Sue-Ling HM, May J, Miller GV, Martin IG, et al. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut. 1997;41(3):314–9.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Sheybani A, Menias CO, Luna A, Fowler KJ, Hara AK, Silva AC, et al. Mri of the stomach: a pictorial review with a focus on oncological applications and gastric motility. Abdom Imaging. 2015;40(4):907–30.PubMedCrossRefGoogle Scholar
  25. 25.
    Malibari N, Hickeson M, Lisbona R. Pet/computed tomography in the diagnosis and staging of gastric cancers. PET Clin. 2015;10(3):311–26.PubMedCrossRefGoogle Scholar
  26. 26.
    Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. Fdg pet imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging. 2003;30(2):288–95.PubMedCrossRefGoogle Scholar
  27. 27.
    Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer. 2005;103(11):2383–90.PubMedCrossRefGoogle Scholar
  28. 28.
    Yeung HW, Macapinlac H, Karpeh M, Finn RD, Larson SM. Accuracy of fdg-pet in gastric cancer. Preliminary experience. Clin Positron Imaging. 1998;1(4):213–21.PubMedCrossRefGoogle Scholar
  29. 29.
    Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallbohmer D, et al. Variable 18f-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of glut-1 expression. Nucl Med Commun. 2010;31(6):532–8.PubMedGoogle Scholar
  30. 30.
    Berger KL, Nicholson SA, Dehdashti F, Siegel BA. Fdg pet evaluation of mucinous neoplasms: correlation of fdg uptake with histopathologic features. AJR Am J Roentgenol. 2000;174(4):1005–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys. 1990;19(6):1357–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Lehnert T, Rudek B, Buhl K, Golling M. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol. 2002;28(4):455–61.PubMedCrossRefGoogle Scholar
  33. 33.
    Roukos DH. Extended (d2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol. 2000;7(4):253–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with fdg pet imaging: physiologic and benign variants. Radiographics. 1999;19(1):61–77; quiz 150-151.PubMedCrossRefGoogle Scholar
  35. 35.
    Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29(2):347–73.PubMedCrossRefGoogle Scholar
  36. 36.
    Low RN. Mr imaging of the peritoneal spread of malignancy. Abdom Imaging. 2007;32(3):267–83.PubMedCrossRefGoogle Scholar
  37. 37.
    Vicens RA, Patnana M, Le O, Bhosale PR, Sagebiel TL, Menias CO, et al. Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists. Abdom Imaging. 2015;40(2):436–56.PubMedCrossRefGoogle Scholar
  38. 38.
    Park CM, Kim SH, Kim SH, Moon MH, Kim KW, Choi HJ. Recurrent ovarian malignancy: patterns and spectrum of imaging findings. Abdom Imaging. 2003;28(3):404–15.PubMedCrossRefGoogle Scholar
  39. 39.
    Hamrick-Turner JE, Chiechi MV, Abbitt PL, Ros PR. Neoplastic and inflammatory processes of the peritoneum, omentum, and mesentery: diagnosis with ct. Radiographics. 1992;12(6):1051–68.PubMedCrossRefGoogle Scholar
  40. 40.
    Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993;72(5):1631–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Walkey MM, Friedman AC, Sohotra P, Radecki PD. Ct manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol. 1988;150(5):1035–41.PubMedCrossRefGoogle Scholar
  42. 42.
    Whitley NO, Bohlman ME, Baker LP. Ct patterns of mesenteric disease. J Comput Assist Tomogr. 1982;6(3):490–6.PubMedCrossRefGoogle Scholar
  43. 43.
    De Gaetano AM, Calcagni ML, Rufini V, Valenza V, Giordano A, Bonomo L. Imaging of peritoneal carcinomatosis with fdg pet-ct: diagnostic patterns, case examples and pitfalls. Abdom Imaging. 2009;34(3):391–402.PubMedCrossRefGoogle Scholar
  44. 44.
    Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)f-fdg pet. J Nucl Med. 2003;44(9):1407–12.PubMedGoogle Scholar
  45. 45.
    Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101(3):518–26.PubMedCrossRefGoogle Scholar
  46. 46.
    Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249(1):63–71.PubMedCrossRefGoogle Scholar
  47. 47.
    Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16(7):781–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Reynolds I, Healy P, McNamara DA. Malignant tumours of the small intestine. Surgeon. 2014;12(5):263–70.PubMedCrossRefGoogle Scholar
  49. 49.
    Kadakia SC, Parker A, Canales L. Metastatic tumors to the upper gastrointestinal tract: endoscopic experience. Am J Gastroenterol. 1992;87(10):1418–23.PubMedGoogle Scholar
  50. 50.
    Algin O, Evrimler S, Arslan H. Advances in radiologic evaluation of small bowel diseases. J Comput Assist Tomogr. 2013;37(6):862–71.PubMedCrossRefGoogle Scholar
  51. 51.
    Horton KM, Juluru K, Montogomery E, Fishman EK. Computed tomography imaging of gastrointestinal stromal tumors with pathology correlation. J Comput Assist Tomogr. 2004;28(6):811–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Druce M, Rockall A, Grossman AB. Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol. 2009;5(5):276–83.PubMedCrossRefGoogle Scholar
  53. 53.
    Masselli G, Gualdi G. Mr imaging of the small bowel. Radiology. 2012;264(2):333–48.PubMedCrossRefGoogle Scholar
  54. 54.
    Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of mr enteroclysis with mr enterography and conventional enteroclysis in patients with crohn's disease. Eur Radiol. 2008;18(3):438–47.PubMedCrossRefGoogle Scholar
  55. 55.
    Das CJ, Manchanda S, Panda A, Sharma A, Gupta AK. Recent advances in imaging of small and large bowel. PET Clin. 2016;11(1):21–37.PubMedCrossRefGoogle Scholar
  56. 56.
    Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R. Malignant tumours of the small intestine: a review of histopathology, multidetector ct and mri aspects. Br J Radiol. 2011;84(1004):677–90.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Tan EH, Tan CH. Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol. 2011;2(1):28–43.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Maxwell JE, Howe JR. Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol. 2015;2(2):159–68.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Sundin A. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol [Review]. 2012;26(6):803–18.CrossRefGoogle Scholar
  60. 60.
    Jain TK, Karunanithi S, Dhull VS, Roy SG, Kumar R. Carcinoma of unknown primary of neuroendocrine origin: accurate detection of primary with (68)ga-labelled [1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid]-1-nai3-octreotide positron emission tomography/computed tomography enterography. Indian J Nucl Med. 2014;29(2):122–3.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Krausz Y, Freedman N, Rubinstein R, Lavie E, Orevi M, Tshori S, et al. 68ga-dota-noc pet/ct imaging of neuroendocrine tumors: comparison with (1)(1)(1)in-dtpa-octreotide (octreoscan(r)). Mol Imaging Biol [Clinical Trial Comparative Study]. 2011;13(3):583–93.CrossRefGoogle Scholar
  62. 62.
    Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–502.PubMedCrossRefGoogle Scholar
  63. 63.
    Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.PubMedCrossRefGoogle Scholar
  64. 64.
    Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.PubMedCrossRefGoogle Scholar
  67. 67.
    Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, et al. Mr imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics. 2012;32(2):389–409.PubMedCrossRefGoogle Scholar
  68. 68.
    Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc. 1989;3(2):96–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution mr imaging with histopathologic comparison. Radiology. 2003;227(2):371–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum. 1990;33(7):598–601.PubMedCrossRefGoogle Scholar
  71. 71.
    Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.PubMedCrossRefGoogle Scholar
  72. 72.
    Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36(6):2251–70.PubMedCrossRefGoogle Scholar
  73. 73.
    Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594–642.PubMedCrossRefGoogle Scholar
  74. 74.
    Levine MS, Yee J. History, evolution, and current status of radiologic imaging tests for colorectal cancer screening. Radiology. 2014;273(2 Suppl):S160–80.PubMedCrossRefGoogle Scholar
  75. 75.
    Baker ME, Bogoni L, Obuchowski NA, Dass C, Kendzierski RM, Remer EM, et al. Computer-aided detection of colorectal polyps: can it improve sensitivity of less-experienced readers? Preliminary findings. Radiology. 2007;245(1):140–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Dachman AH, Obuchowski NA, Hoffmeister JW, Hinshaw JL, Frew MI, Winter TC, et al. Effect of computer-aided detection for ct colonography in a multireader, multicase trial. Radiology. 2010;256(3):827–35.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Petrick N, Haider M, Summers RM, Yeshwant SC, Brown L, Iuliano EM, et al. Ct colonography with computer-aided detection as a second reader: observer performance study. Radiology. 2008;246(1):148–56.PubMedCrossRefGoogle Scholar
  78. 78.
    Regge D, Della Monica P, Galatola G, Laudi C, Zambon A, Correale L, et al. Efficacy of computer-aided detection as a second reader for 6-9-mm lesions at ct colonography: Multicenter prospective trial. Radiology. 2013;266(1):168–76.PubMedCrossRefGoogle Scholar
  79. 79.
    Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. Ct colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007;357(14):1403–12.PubMedCrossRefGoogle Scholar
  80. 80.
    Kim DH, Pooler BD, Weiss JM, Pickhardt PJ. Five year colorectal cancer outcomes in a large negative ct colonography screening cohort. Eur Radiol. 2012;22(7):1488–94.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ali Devrim Karaosmanoglu
    • 1
  • Mehmet Ruhi Onur
    • 1
  • Ronald S. Arellano
    • 2
  1. 1.Department of RadiologyHacettepe University, School of MedicineSıhhiyeTurkey
  2. 2.Department of RadiologyHarvard Medical School, Massachusetts General HospitalBostonUSA

Personalised recommendations